John B Henneman Iii R1 Rcm Inc. (RCM) insider trading activity

John B Henneman Iii is Director of R1 RCM Inc. . Currently has a direct ownership of 87,765 shares of RCM, which is worth approximately $1.25 Million. The most recent transaction as insider was on May 23, 2024, when has been sold 15,651 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.8K

0% 3M change

21.7% 12M change

Total Value Held $1.25 Million

JOHN B HENNEMAN III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	BUY Grant, award, or other acquisition	-	15,651 Added 15.13%	87,765 Common Stock
Aug 08 2023	SELL Open market or private sale	$858,500 $17.17 p/Share	50,000 Reduced 40.95%	72,114 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	$130,500 $2.61 p/Share	50,000 Added 29.05%	122,114 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	11,324 Added 13.57%	72,114 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	-	60,790 Added 50.0%	60,790 Common Stock

Also insider at

ANIK

Anika Therapeutics, Inc. Healthcare

Director

SPNE

SeaSpine Holdings Corp Healthcare

Director

APRE

Aprea Therapeutics, Inc. Healthcare

Director

OFIX

Orthofix Medical Inc. Healthcare

JBH